ANTI CANCER MEDICATION
150 mg Eriocip 150 Erlotinib IP Tablets
Price on Request
Eriocip (Erlotinib) 150 mg is a targeted prescription medication used to treat metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. Manufactured by Cipla, it acts as an epidermal growth factor receptor (EGFR) inhibitor to slow the growth and spread of cancer cells.
liketo,usa.uk.china.southkorea.russia.japan.singapore
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Strength 150 mg
Dose/Strength 150 mg
Company Cipla
Usage Lung cancer
Brand Erlocip
Shelf Life 24 months
Form Tablet
Manufacturer Cipla Ltd
Country of Origin Made in India
Pack Size 30 Tablets
Therapeutic Uses Pharmacy dropshipper
Composition Erlotinib Tablets IP
Minimum order quantity: 50 Bottle
Enquire About This Product
